Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

被引:195
|
作者
Papadimitropoulos, E
Wells, G
Shea, B
Gillespie, W
Weaver, B
Zytaruk, N
Cranney, A
Adachi, J
Tugwell, P
Josse, R
Greenwood, C
Guyatt, G
机构
[1] McMaster University, Department of Clinical Epidemiology, Hamilton, Ont. L8N 3Z5
关键词
D O I
10.1210/er.2001-8002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To review the effect of vitamin D on bone density and fractures in postmenopausal women. Data Source: We searched MEDLINE and EMBASE from 1966 to 1999 and examined citations of relevant articles and proceedings of international meetings. We contacted osteoporosis investigators and primary authors to identify additional studies and to obtain unpublished data. Study Selection: We included 25 trials that randomized women to standard or hydroxylated vitamin D with or without calcium supplementation or a control and measured bone density or fracture incidence for at least 1 yr. Data Extraction: For each trial, three independent reviewers assessed the methodological quality and abstracted data. Data Synthesis: Vitamin D reduced the incidence of vertebral fractures [relative risk (RR) 0.63, 95% confidence interval (Cl) 0.45-0.88, P < 0.01] and showed a trend toward reduced incidence of nonvertebral fractures (RR 0.77,95% Cl 0.57-1.04, P = 0.09). Most patients in the trials that evaluated vertebral fractures received hydroxylated vitamin D, and most patients in the trials that evaluated nonvertebral fractures received standard vitamin D. Hydroxylated vitamin D had a consistently larger impact on bone density than did standard vitamin D. For instance, total body differences in percentage change between hydroxylated vitamin D and control were 2.06 (0.72, 3.40) and 0.40 (- 0.25,1.06) for standard vitamin D. At the lumbar spine and forearm sites, hydroxylated vitamin D doses above 50 mug yield larger effects than lower doses. Vitamin D resulted in an increased risk of discontinuing medication in comparison to control as a result of either symptomatic adverse effects or abnormal laboratory results (RR 1.37,95% CI 1.01-1.88), an effect that was similar in trials of standard and hydroxylated vitamin D. Conclusions: Vitamin D decreases vertebral fractures and may decrease nonvertebral fractures. The available data are uninformative regarding the relative effects of standard and hydroxylated vitamin D.
引用
收藏
页码:560 / 569
页数:10
相关论文
共 50 条
  • [31] Denosumab versus bisphosphonates for treatment of postmenopausal osteoporosis: a meta-analysis
    Lan, Xiaoyong
    Ma, Haiping
    Zhang, Zhiping
    Ye, Dong
    Min, Jun
    Cai, Feng
    Luo, Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11037 - 11048
  • [32] The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis
    Xu, Fuxin
    Wang, Yurun
    Zhu, Xinjian
    [J]. CLINICAL THERAPEUTICS, 2024, 46 (03) : 267 - 274
  • [33] Efficacy of vitamin D in treatment of inflammatory bowel disease A meta-analysis
    Li, Jinzhong
    Chen, Ning
    Wang, Dan
    Zhang, Jie
    Gong, Xiaobing
    [J]. MEDICINE, 2018, 97 (46)
  • [34] Efficacy of vitamin D in the treatment of depression: a systematic review and meta-analysis
    Lazaro Tome, Ana
    Jose Reig Cebria, Ma
    Gonzalez-Teruel, Aurora
    Antonio Carbonell-Asins, Juan
    Canete Nicolas, Carlos
    Hernandez-Viadel, Miguel
    [J]. ACTAS ESPANOLAS DE PSIQUIATRIA, 2021, 49 (01): : 12 - 23
  • [35] Impact of calcium, vitamin D, vitamin K, oestrogen, isoflavone and exercise on bone mineral density for osteoporosis prevention in postmenopausal women: a network meta-analysis
    Xu, Zijun
    Wang, Huwen
    Shi, Yue
    Shen, Qiuming
    Tsamlag, Lhakpa
    Wang, Zezhou
    Yu, Shoukai
    Shen, Tian
    Wang, Ying
    Cai, Yong
    [J]. BRITISH JOURNAL OF NUTRITION, 2020, 123 (01) : 84 - 103
  • [36] Comparative efficacy and safety of pharmacological interventions for osteoporosis in postmenopausal women: a network meta-analysis (Chongqing, China)
    Tan, Xiang
    Wen, Fei
    Yang, Wei
    Xie, Ji-Yong
    Ding, Liang-Liang
    Mo, Yu-Xia
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (08): : 929 - 939
  • [37] Comparative efficacy between monoclonal antibodies and conventional drugs in postmenopausal women with osteoporosis: a network meta-analysis
    Jiang, Qingtao
    Zhang, Feng
    Zhu, Baoli
    Zhang, Hengdong
    Han, Lei
    Liu, Xin
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (02) : 1693 - +
  • [38] Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis
    von Keyserlingk, Camilla
    Hopkins, Robert
    Anastasilakis, Athanasios
    Toulis, Konstantinos
    Goeree, Ron
    Tarride, Jean-Eric
    Xie, Feng
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 178 - 186
  • [39] Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis
    Gao, Sasa
    Zhao, Yongfang
    [J]. QUALITY OF LIFE RESEARCH, 2023, 32 (06) : 1551 - 1565
  • [40] Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis
    Sasa Gao
    Yongfang Zhao
    [J]. Quality of Life Research, 2023, 32 : 1551 - 1565